Infiltrating CD3+ and CD8+ T cells were significantly reduced in IL-38-transfected tumours, suggesting that IL-38 inhibits the recruitment of CD8+ T cells during lung cancer development. This evidence concerns the gene IL1F10 and lung carcinoma.